Thurston Springer Miller Herd & Titak’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.2K Buy
180
+17
+10% +$2.55K 0.01% 596
2026
Q1
$24.9K Sell
163
-13
-7% -$1.99K 0.01% 715
2025
Q4
$24.3K Buy
176
+170
+2,833% +$22.3K 0.01% 692
2025
Q3
$769 Sell
6
-1,810
-100% -$221K ﹤0.01% 511
2025
Q2
$220K Buy
1,816
+109
+6% +$12.3K 0.03% 353
2025
Q1
$190K Buy
1,707
+19
+1% +$2.02K 0.03% 331
2024
Q4
$164K Buy
1,688
+1,077
+176% +$115K 0.03% 300
2024
Q3
$70.3K Buy
611
+24
+4% +$2.72K 0.02% 478
2024
Q2
$62.5K Buy
+587
New +$58.9K 0.02% 511

Other funds holding NVS